> News > Diaclone and SEED Biosciences collaborate on the development of a new workflow for rapid antibody discovery
18.02
2021

Diaclone and SEED Biosciences collaborate on the development of a new workflow for rapid antibody discovery

Diaclone and Seed Biosciences collaborate to optimize a new workflow for a faster and more efficient antibody  development process.

 

Read full news

Company related to the news